A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol(LDL-C)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This Phase I/II clinical trial is designed to evaluate, through a single-dose Phase I segment and a multiple-dose Phase II segment, the safety/tolerability, pharmacokinetic (PK) profile, and pharmacodynamic (PD) characteristics of BEBT-701 administered by subcutaneous injection in patients with mild to moderate hypertension and elevated LDL-C , and to explore its preliminary efficacy.
Epistemonikos ID: ac6d0e063005fd9826e0bb854582f8ff4debaf91
First added on: Jan 27, 2026